MacroGenics, Inc.
MGNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$66,966 | -$9,058 | -$119,758 | -$202,115 |
| Dep. & Amort. | $7,540 | $9,645 | $11,865 | $11,258 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $29,439 | $0 | $20,438 | $23,126 |
| Change in WC | $1,392 | $53,316 | -$6,130 | $17,569 |
| Other Non-Cash | -$39,778 | -$132,108 | $6,626 | $6,332 |
| Operating Cash Flow | -$68,373 | -$78,205 | -$86,959 | -$143,830 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,706 | -$1,764 | -$3,623 | -$6,201 |
| Net Acquisitions | $0 | $64 | $0 | $0 |
| Inv. Purchases | -$77,182 | -$239,683 | -$120,602 | -$231,208 |
| Inv. Sales/Matur. | $190,025 | $161,299 | $194,940 | $200,800 |
| Other Inv. Act. | $40,160 | $0 | $0 | $0 |
| Investing Cash Flow | $149,297 | -$80,084 | $70,715 | -$36,609 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$157 | $0 | $0 |
| Stock Issued | $0 | $1,169 | $1,085 | $117,818 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $960 | $149,349 | $574 | $4,959 |
| Financing Cash Flow | $960 | $150,361 | $1,659 | $122,777 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $81,884 | -$7,928 | -$14,585 | -$57,662 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $100,956 | $108,884 | $123,469 | $181,131 |
| End Cash | $182,840 | $100,956 | $108,884 | $123,469 |
| Free Cash Flow | -$72,079 | -$79,969 | -$90,582 | -$150,031 |